|
(b)(4).Date sent to the fda: 9/21/2021.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional h3 investigation summary: visual analysis of the returned product revealed that one suture product code z339 was received to ethicon inc for evaluation.Upon visual inspection of the returned sample, the suture was received cutted, damages at the surface, in addition, the ends were observed with stress.After further evaluation crimping marks were observed on the surface suture possibly from a surgical instrument.The product code z339 contains absorbable suture, as the sample was received open, the time of exposed to the environment could not be determined and functional test cannot be performed.The manufacturing records couldn't be reviewed as the batch number is unknown.The condition of the sample received indicates improper handling of the device.As part of ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.
|